No photo of Anat Roitberg-Tambur

View Scopus Profile

Anat Roitberg-Tambur

  • 2558 Citations
1990 …2023

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

HLA epitopes, TRANSPLANT IMMUNOLOGY, HUMORAL IMMUNOTY, HLA ANTIBODEIS,

Education/Academic qualification

DMD, PhD, Hebrew University of Jerusalem

… → 1987

Research interests

  • Immunogenetics
  • Immunology
  • Transplantation

Fingerprint Dive into the research topics where Anat Roitberg-Tambur is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 21 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

A Phase 2 Open-label, Prospective, Randomized Study of Inebilizumab, VIB4920, or the Combination to Evaluate Safety and Tolerability in highly sensitized candidates awaiting kidney transplantation from a deceased donor

Roitberg-Tambur, A.

Viela Bio, Inc

12/13/19 → 6/30/23

Project: Research project

    • Analyzing the Immunogenicity of HLA-DQ in solid organ transplantation

    Roitberg-Tambur, A.

    Vanguard Charitable Endowment Program

    12/1/19 → 11/30/20

    Project: Research project

    • HLA-DQ Immunogenicity and Its Role in Antibody Mediated Rejection in Solid Organ Transplantation

    Roitberg-Tambur, A.

    Vanguard Charitable Endowment Program

    9/1/18 → 8/31/21

    Project: Research project

    • HLA Epitopes in Organ Transplantation – Clinical Applications

    Roitberg-Tambur, A.

    Vanguard Charitable Endowment Program

    3/1/18 → 2/28/23

    Project: Research project

    • Astagraf XL® to Understand the Impact of Immunosuppression on De Novo DSA Development and Chronic Immune Activation in Kidney Transplantation

    Roitberg-Tambur, A.

    Astellas Pharma Global Development, Inc.

    7/31/16 → 3/31/20

    Project: Research project

    • Research Output

    Predicting kidney transplant outcomes with partial knowledge of HLA mismatch

    Manski, C. F., Tambur, A. R. & Gmeiner, M., Oct 8 2019, In : Proceedings of the National Academy of Sciences of the United States of America. 116, 41, p. 20339-20345 7 p.

    Research output: Contribution to journal › Article

    Open Access

    • Prognostic tools to assess candidacy for and efficacy of antibody-removal therapy

    Pinelli, D. F., Zachary, A. A., Friedewald, J. J., Gjertson, D. W., Evans, M. A., Chatroop, E. N., Leffell, M. S., Vo, A. A., Jordan, S. C., Montgomery, R. A. & Tambur, A. R., Feb 1 2019, In : American Journal of Transplantation. 19, 2, p. 381-390 10 p.

    Research output: Contribution to journal › Article

    • 4 Scopus citations

    The quest to decipher HLA immunogenicity: Telling friend from foe

    Tambur, A. R., McDowell, H., Hod-Dvorai, R., Abundis, M. A. C. & Pinelli, D. F., Oct 1 2019, In : American Journal of Transplantation. 19, 10, p. 2910-2925 16 p.

    Research output: Contribution to journal › Article

    • A call to action—The transplant recipient's expectation of precision in transplant medicine

    Wiebe, C., Roitberg-Tambur, A. & Nickerson, P. W., Dec 1 2018, In : American Journal of Transplantation. 18, 12, p. 2845-2846 2 p.

    Research output: Contribution to journal › Editorial

    1 Scopus citations

    HLA Diagnostics: Evaluating DSA Strength by Titration

    Roitberg-Tambur, A. & Wiebe, C., Jan 1 2018, In : Transplantation. 102, 1, p. S23-S30

    Research output: Contribution to journal › Review article

    • 14 Scopus citations